Substandard And Falsified Medicines threaten South Africa as SAHPRA warns informal sales can cause treatment failure, harm and death.
Substandard And Falsified Medicines Threaten South Africa
Original Article by Elna Schütz | Spotlight | 20th May 2026
Substandard And Falsified Medicines threaten South Africa as SAHPRA warns informal sales can cause treatment failure, harm and death.
More Posts
Momentum Group Posts Record Earnings
Momentum Group has posted record earnings, with normalised headline earnings up 13% to R7.06bn – beating its R7bn Impact target a year early.
Read more...
Sanlam Writes Down AfroCentric to Nil but Won’t Sell
Sanlam has written its AfroCentric stake down to nil after the Bonitas exit but rules out a sale, betting it can revive the business.
Read more...
GLP-1 Alone Won’t Solve South Africa’s Diabetes Crisis
GLP-1 medicines alone can’t solve SA’s diabetes crisis, experts warn, urging earlier screening, coordinated care and better food access.
Read more...